Literature DB >> 7755587

Biosynthesis of the glycolipid anchor of lipophosphoglycan and the structurally related glycoinositolphospholipids from Leishmania major.

L Proudfoot1, P Schneider, M A Ferguson, M J McConville.   

Abstract

The major macromolecule on the surface of the protozoan parasite Leishmania major is a lipophosphoglycan (LPG) which contains a glycosylphosphatidylinositol glycolipid anchor. This parasite also synthesizes a complex family of abundant low-molecular-mass glycoinositolphospholipids (GIPLs) which are structurally related to the LPG anchor. In this study, L. major promastigotes were metabolically labelled with [3H]GlcN, and the kinetics of incorporation into free glycolipids and the LPG anchor followed to elucidate the pathway of GIPL biosynthesis and possible precursor-product relationships between the GIPLs and LPG. Labelled GIPLs were identified by TLC and by liquid chromatography of the released headgroups, before and after enzymic and chemical cleavage. On the basis of the measured specific radioactivities of the GIPLs, and their kinetics of radiolabelling, we suggest the pathway GlcN-PI-->Man1GlcN-PI (M1)-->Man2GlcN-PI (iM2)-->GalfMan2GlcN-PI (GIPL-1)-->Gal1GalfMan2GlcN-PI (GIPL-2)-->Gal2GalfMan2GlcN-PI (GIPL-3). All of the GIPLs were shown to contain alkylacylglycerol or lyso-alkylglycerol lipid moieties with the exception of the earliest intermediate, glucosaminylphosphatidylinositol (GlcN-PI), which contained both alkylacylglycerol and diacylglycerol. A significant proportion (approx. 50%) of GIPL-3 appeared to be selectively modified by the addition of a Glc-1-PO4 residue to one of the mannose residues (P-GIPL-3). On the basis of the specific radioactivity and kinetics of labelling of GIPL-3 and P-GIPL-3 we suggest that both of these low-abundance species are rapidly utilized as LPG precursors. The turnover of LPG and the GIPLs was also studied by [3H]Gal pulse-chase labelling and cell-surface labelling experiments. Whereas LPG was rapidly shed from the cell surface, consistent with previous studies, the GIPLs (both the total cellular and cell-surface pools) had a much slower turnover. These results suggest that the majority of the GIPLs do not act as LPG precursors and indicate that the cellular levels of these molecules is determined, at least in part, by the rate at which they are shed from the cell surface.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7755587      PMCID: PMC1136841          DOI: 10.1042/bj3080045

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  33 in total

1.  Lipophosphoglycan masks recognition of the Leishmania donovani promastigote surface by human kala-azar serum.

Authors:  C L Karp; S J Turco; D L Sacks
Journal:  J Immunol       Date:  1991-07-15       Impact factor: 5.422

2.  Released glycoconjugate of indigenous Leishmania major enhances survival of a foreign L. major in Phlebotomus papatasi.

Authors:  Y Schlein; L F Schnur; R L Jacobson
Journal:  Trans R Soc Trop Med Hyg       Date:  1990 May-Jun       Impact factor: 2.184

3.  Serum resistance of metacyclic stage Leishmania major promastigotes is due to release of C5b-9.

Authors:  S M Puentes; R P Da Silva; D L Sacks; C H Hammer; K A Joiner
Journal:  J Immunol       Date:  1990-12-15       Impact factor: 5.422

4.  A family of glycoinositol phospholipids from Leishmania major. Isolation, characterization, and antigenicity.

Authors:  M J McConville; A Bacic
Journal:  J Biol Chem       Date:  1989-01-15       Impact factor: 5.157

5.  Structure of the lipophosphoglycan from Leishmania major.

Authors:  M J McConville; J E Thomas-Oates; M A Ferguson; S W Homans
Journal:  J Biol Chem       Date:  1990-11-15       Impact factor: 5.157

6.  Cell-free synthesis of glycosyl-phosphatidylinositol precursors for the glycolipid membrane anchor of Trypanosoma brucei variant surface glycoproteins. Structural characterization of putative biosynthetic intermediates.

Authors:  A K Menon; R T Schwarz; S Mayor; G A Cross
Journal:  J Biol Chem       Date:  1990-06-05       Impact factor: 5.157

7.  The glycoinositolphospholipid profiles of two Leishmania major strains that differ in lipophosphoglycan expression.

Authors:  M J McConville; A Bacic
Journal:  Mol Biochem Parasitol       Date:  1990-01-01       Impact factor: 1.759

8.  Structures of the glycoinositolphospholipids from Leishmania major. A family of novel galactofuranose-containing glycolipids.

Authors:  M J McConville; S W Homans; J E Thomas-Oates; A Dell; A Bacic
Journal:  J Biol Chem       Date:  1990-05-05       Impact factor: 5.157

9.  A novel pathway for glycan assembly: biosynthesis of the glycosyl-phosphatidylinositol anchor of the trypanosome variant surface glycoprotein.

Authors:  W J Masterson; T L Doering; G W Hart; P T Englund
Journal:  Cell       Date:  1989-03-10       Impact factor: 41.582

10.  Cell-free biosynthesis of lipophosphoglycan from Leishmania donovani. Characterization of microsomal galactosyltransferase and mannosyltransferase activities.

Authors:  M A Carver; S J Turco
Journal:  J Biol Chem       Date:  1991-06-15       Impact factor: 5.157

View more
  15 in total

1.  Biosynthesis of lipophosphoglycan from Leishmania major: solubilization and characterization of a (beta 1-3)-galactosyltransferase.

Authors:  K Ng; E Handman; A Bacic
Journal:  Biochem J       Date:  1996-07-01       Impact factor: 3.857

2.  Early steps in glycosylphosphatidylinositol biosynthesis in Leishmania major.

Authors:  T K Smith; F C Milne; D K Sharma; A Crossman; J S Brimacombe; M A Ferguson
Journal:  Biochem J       Date:  1997-09-01       Impact factor: 3.857

3.  Lipophosphoglycan is a virulence factor distinct from related glycoconjugates in the protozoan parasite Leishmania major.

Authors:  G F Späth; L Epstein; B Leader; S M Singer; H A Avila; S J Turco; S M Beverley
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-01       Impact factor: 11.205

4.  Role of beta-D-galactofuranose in Leishmania major macrophage invasion.

Authors:  Erika Suzuki; Ameria K Tanaka; Marcos S Toledo; Helio K Takahashi; Anita H Straus
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

Review 5.  Secretory pathway of trypanosomatid parasites.

Authors:  Malcolm J McConville; Kylie A Mullin; Steven C Ilgoutz; Rohan D Teasdale
Journal:  Microbiol Mol Biol Rev       Date:  2002-03       Impact factor: 11.056

6.  Regulation of the expression of nitric oxide synthase and leishmanicidal activity by glycoconjugates of Leishmania lipophosphoglycan in murine macrophages.

Authors:  L Proudfoot; A V Nikolaev; G J Feng; W Q Wei; M A Ferguson; J S Brimacombe; F Y Liew
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

7.  Parasite and mammalian GPI biosynthetic pathways can be distinguished using synthetic substrate analogues.

Authors:  T K Smith; D K Sharma; A Crossman; A Dix; J S Brimacombe; M A Ferguson
Journal:  EMBO J       Date:  1997-11-17       Impact factor: 11.598

8.  Regulated expression of the Leishmania major surface virulence factor lipophosphoglycan using conditionally destabilized fusion proteins.

Authors:  Luciana Madeira da Silva; Katherine L Owens; Silvane M F Murta; Stephen M Beverley
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-21       Impact factor: 11.205

9.  Sugar nucleotide pools of Trypanosoma brucei, Trypanosoma cruzi, and Leishmania major.

Authors:  Daniel C Turnock; Michael A J Ferguson
Journal:  Eukaryot Cell       Date:  2007-06-08

10.  Protective role of the neuropeptide urocortin II against experimental sepsis and leishmaniasis by direct killing of pathogens.

Authors:  Jenny Campos-Salinas; Marta Caro; Antonio Cavazzuti; Irene Forte-Lago; Stephen M Beverley; Francisco O'Valle; Elena Gonzalez-Rey
Journal:  J Immunol       Date:  2013-11-18       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.